tiprankstipranks
Merck & Company (DE:6MK)
XETRA:6MK
Want to see DE:6MK full AI Analyst Report?

Merck & Company (6MK) Stock Statistics & Valuation Metrics

69 Followers

Total Valuation

Merck & Company has a market cap or net worth of €233.85B. The enterprise value is €318.88B.
Market Cap€233.85B
Enterprise Value€318.88B

Share Statistics

Merck & Company has 2,469,824,500 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,469,824,500
Owned by Insiders0.05%
Owned by Institutions7.09%

Financial Efficiency

Merck & Company’s return on equity (ROE) is 0.35 and return on invested capital (ROIC) is 18.27%.
Return on Equity (ROE)0.35
Return on Assets (ROA)0.13
Return on Invested Capital (ROIC)18.27%
Return on Capital Employed (ROCE)0.22
Revenue Per Employee889.40K
Profits Per Employee250.05K
Employee Count73,000
Asset Turnover0.47
Inventory Turnover2.73

Valuation Ratios

The current PE Ratio of Merck & Company is ―. Merck & Company’s PEG ratio is 1.81.
PE Ratio
PS Ratio4.06
PB Ratio5.01
Price to Fair Value5.01
Price to FCF21.31
Price to Operating Cash Flow15.39
PEG Ratio1.81

Income Statement

In the last 12 months, Merck & Company had revenue of 64.93B and earned 18.25B in profits. Earnings per share was 7.30.
Revenue64.93B
Gross Profit46.73B
Operating Income23.49B
Pretax Income21.07B
Net Income18.25B
EBITDA29.32B
Earnings Per Share (EPS)7.30

Cash Flow

In the last 12 months, operating cash flow was 17.89B and capital expenditures -3.77B, giving a free cash flow of 14.12B billion.
Operating Cash Flow17.89B
Free Cash Flow14.12B
Free Cash Flow per Share5.71

Dividends & Yields

Merck & Company pays an annual dividend of €0.723, resulting in a dividend yield of 3.18%
Dividend Per Share€0.723
Dividend Yield3.18%
Payout Ratio38.61%
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.54
52-Week Price Change37.89%
50-Day Moving Average101.46
200-Day Moving Average83.31
Relative Strength Index (RSI)43.11
Average Volume (3m)1.78K

Important Dates

Merck & Company upcoming earnings date is Aug 4, 2026, Before Open (Confirmed).
Last Earnings DateApr 30, 2026
Next Earnings DateAug 4, 2026
Ex-Dividend Date

Financial Position

Merck & Company as a current ratio of 1.54, with Debt / Equity ratio of 107.06%
Current Ratio1.54
Quick Ratio1.30
Debt to Market Cap0.19
Net Debt to EBITDA1.23
Interest Coverage Ratio17.31

Taxes

In the past 12 months, Merck & Company has paid 2.80B in taxes.
Income Tax2.80B
Effective Tax Rate0.13

Enterprise Valuation

Merck & Company EV to EBITDA ratio is 10.21, with an EV/FCF ratio of 24.22.
EV to Sales4.61
EV to EBITDA10.21
EV to Free Cash Flow24.22
EV to Operating Cash Flow18.17

Balance Sheet

Merck & Company has €5.70B in cash and marketable securities with €49.12B in debt, giving a net cash position of -€43.41B billion.
Cash & Marketable Securities€5.70B
Total Debt€49.12B
Net Cash-€43.41B
Net Cash Per Share-€17.58
Tangible Book Value Per Share€1.76

Margins

Gross margin is 75.91%, with operating margin of 36.17%, and net profit margin of 28.12%.
Gross Margin75.91%
Operating Margin36.17%
Pretax Margin32.45%
Net Profit Margin28.12%
EBITDA Margin45.17%
EBIT Margin36.17%

Analyst Forecast

The average price target for Merck & Company is €116.22, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target€116.22
Price Target Upside17.07% Upside
Analyst ConsensusModerate Buy
Analyst Count20
Revenue Growth Forecast-4.86%
EPS Growth Forecast-51.78%

Scores

Smart Score6
AI Score